Patient Support & Advocacy
AMA advocacy 2020-2021 efforts
The AMA advocates at the federal and state levels on key health care issues impacting patients and physicians. See updates of our some of our recent efforts.
Why a federal court upheld ban on flavored tobacco products
The AMA and other advocates outlined the positive impact a San Diego ban will have on the health of young people and Black people.
AMA in the News
AMA in the News: April 2021
Read media highlights mentioning the American Medical Association for April 2021.
Publications & Newsletters
Top news stories from AMA Morning Rounds®: Week of April 26, 2021
In the news: Pause lifted on Johnson & Johnson vaccine, U.S. population growth slowest since 1930s, CDC guidance on masks, FDA to ban menthol in tobacco products, vaccinated seniors less likely to be hospitalized.
Why FDA’s move to ban menthol flavoring is long overdue
Experts estimate that nearly 1 million Americans—and about 230,000 Black Americans—would quit within two years of a menthol cigarette ban’s taking effect.
FDA agrees to ban menthol to protect African Americans
Today’s action by the FDA to ban menthol-flavored cigarettes is a major step toward preventing a new generation from becoming tobacco users and saving lives.
Council on Science & Public Health
Public health: CSAPH reports
Read reports on this topic for the Council on Science & Public Health (CSAPH) presented during the AMA Interim and Annual Meetings.
Membership Moves Medicine™
- Free access to JAMA Network™ and CME
- Save hundreds on insurance
- Fight for physicians and patient rights